TempraMed Secures New South Korea Patent for VIVI...
Category : Product Related Updates 17 December 2025TempraMed Technologies has strengthened its global intellectual property portfolio with a newly gran...
TempraMed Technologies has strengthened its global intellectual property portfolio with a newly gran...
"As both Novo Nordisk and Eli Lilly race to develop their long-anticipated oral GLP-1 obesity m...
Obesity Week 2025 delivered a major update in obesity care: new clinical findings show that a daily...
Japan has taken a major step toward accelerating access to next-generation gene therapies. AskBio, a...
Chronic pain management is stuck in an old loop—opioids, short-acting therapies, and inconsist...